Ascella Health.

Case Study:

Result.

thought leadership pieces secured in key trade titles in 2023, plus 2 expert guides developed.

Result.

award wins.

Result.

pieces of coverage secured 12 months 2022.

Initially under the new name of Terebellum – which was changed the AscellaHealth EU in mid-2023 – the successful US-based business was essentially starting from scratch in a new market. In October 2022, the team turned to Viva to be their communications partner for this region.

AscellaHealth is a global pharmaceutical and healthcare services consultancy specialising in streamlining access to speciality, rare disease treatments and cell and gene therapies.

The team works with those developing novel treatments, payers, and healthcare providers to navigate the complex arena of market access to ensure they can reach the people who need it most – patients.

HQ-ed in Pennsylvania, US, the company expanded in the UK in 2022 to service the growing rare and orphan disease biotech market here.

It needed to raise brand awareness in the healthcare and pharma markets to support its global expansion strategy through a mix of media relations and award entries.

AscellaHealth needed an agency that understood the market and could get to grips with a complex topic to create compelling bylines for its key spokespeople.

A year into working together, Viva has supported AscellaHealth by securing more than 40 pieces of media coverage, two award wins, created two guides to support lead generation and market awareness, and developed a LinkedIn profile for MD, Craig Caceci.

Our brand awareness work with AscellaHealth included:

• Key messaging and themes development

We first supported AscellaHealth (then Terebellum) with its UK market positioning. One of the initial tasks was for Viva to adapt complex, US-focused content for the UK — staying true to the original while making it resonate with the local audience.

• Media Relations

We developed a media campaign from scratch for an entirely unknown entity — from raising awareness of the launch and offering in the UK, to creating news releases and securing interviews for key team members. We also supported AscellaHealth’s first UK client, NeuroSolv, in announcing its breakthrough spinal injury treatment.

• Thought leadership

We successfully pitched and secured exclusives with key trade outlets, including Rare Revolution Magazine and Drug Discovery World, for the company’s SMEs. We’ve also developed LinkedIn posts for MD Craig Caceci, covering industry news, AscellaHealth updates, and their presence at major trade shows.

• Creating owned content

We have worked on unique owned content in the form of Market Access Guides aimed at stakeholders in the supply chain which sit behind a content capture form on the AscellaHealth website.